NGM BIOPHARMACEUTICALS INC Share-based Payment Arrangement, Expense
NGM BIOPHARMACEUTICALS INC reported Share-based Payment Arrangement, Expense of $76.00 thousand for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-05.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2021-08-05
- NGM BIOPHARMACEUTICALS INC share-based payment arrangement, expense for the quarter ending 2021-06-30 was $76.00K, a 117.14% increase year-over-year.
- NGM BIOPHARMACEUTICALS INC share-based payment arrangement, expense for the quarter ending 2021-03-31 was $67.00K, a 139.29% increase year-over-year.
- NGM BIOPHARMACEUTICALS INC share-based payment arrangement, expense for the quarter ending 2020-06-30 was $35.00K.
- NGM BIOPHARMACEUTICALS INC share-based payment arrangement, expense for the quarter ending 2020-03-31 was $28.00K.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month |
|---|---|---|
| 2021-06-30 | $76.00K 10-Q · filed 2021-08-05 | $143.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $67.00K 10-Q · filed 2021-05-06 | |
| 2020-06-30 | $35.00K 10-Q · filed 2021-08-05 | $63.00K 10-Q · filed 2021-08-05 |
| 2020-03-31 | $28.00K 10-Q · filed 2021-05-06 |